Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02135874 · OUTCOME

Participants Complete Response

Clofarabine, Idarubicin, Cytarabine, Vincristine Sulfate, and Dexamethasone in Treating Patients With Newly Diagnosed or Relapsed Mixed Phenotype Acute Leukemia · Source last updated 2024-03-22

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
Up to 2 months

What was measured

Response is Complete Response (CR) is Neutrophil count \>/= 1.0 x 10\^9/L, . Platelet count \>/= 100 x 10\^9/L, Bone marrow aspirate \< 5% blasts, No extramedullary leukemia.

Groups in this outcome

Treatment (Combination Chemotherapy)

See Detailed Description. Clofarabine: Given IV Cytarabine: Given IV Dexamethasone: Given IV Idarubicin: Given IV Rituximab: Given IV Sorafenib: Given PO Sorafenib Tosylate: Given PO Vincristine: Given IV Vincristine Sulfate: Given IV

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Treatment (Combination Chemotherapy)16

Reported measurements

Source class 1
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Treatment (Combination Chemotherapy)9Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        9
denoms
  1. counts
    1. group Id
      OG000
      value
      16
    units
    Participants
description
Response is Complete Response (CR) is Neutrophil count \>/= 1.0 x 10\^9/L, . Platelet count \>/= 100 x 10\^9/L, Bone marrow aspirate \< 5% blasts, No extramedullary leukemia.
groups
  1. description
    See Detailed Description. Clofarabine: Given IV Cytarabine: Given IV Dexamethasone: Given IV Idarubicin: Given IV Rituximab: Given IV Sorafenib: Given PO Sorafenib Tosylate: Given PO Vincristine: Given IV Vincristine Sulfate: Given IV
    id
    OG000
    title
    Treatment (Combination Chemotherapy)
param Type
COUNT_OF_PARTICIPANTS
reporting Status
POSTED
time Frame
Up to 2 months
title
Participants Complete Response
type
PRIMARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice